Valvular & structural heart disease

Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgery

Eur Heart J Cardiovasc ImagingPublished Retrospective cohort study

Authors' conclusion

Waiting for the onset of Class I or isolated Class IIa triggers before operating on DMR patients is associated with postoperative survival loss.

Study context

Population
Patients undergoing surgical correction of severe degenerative mitral regurgitation, Mitral Regurgitation International Database registry603 deaths
Participants
2,833 patients
Exposure
Class I trigger vs Class IIa trigger vs No trigger
  • Class I triggern = 1,677
  • Class IIa triggern = 568
  • No triggern = 588reference
Outcome
Long-term postoperative survival
Follow-up
10 years
Methodological detailsinternational registry (MIDA), matched
  • International registry (MIDA)
  • Matched

Main finding

As reported in the abstract

Postoperative survival
Class I trigger
Restricted mean survival time (RMST) survival loss 9.4 months; P < 0.001
Class IIa trigger
RMST survival loss 4.9 months; P = 0.001

Observational data: associations, not effects.

Further findings

OutcomeValuesHR (95% CI)P value
Mortality by trigger class — Several Class I criteria vs No trigger · additional death risk1.53 (1.42–1.66)
Mortality by trigger class — Class IIa trigger vs No trigger1.46 (1.00–2.13)P = 0.05
OutcomeValuesEstimateP value
Postoperative survival, isolated PH vs none (Class IIa subgroup)Isolated PH 83.7 ± 2.8 % · No PH 89.3 ± 1.6 %P = 0.011
Postoperative survival, AF vs none (Class IIa subgroup)AF 81.8 ± 5.0 % · No AF 88.3 ± 1.5 %P = 0.023
Mortality by trigger class — ≥1 Class I criterion led to excess mortality
P < 0.001

Original publication

Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgery. Eur Heart J Cardiovasc Imaging. Published 12 July 2024. doi:10.1093/ehjci/jeae176

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.